150 related articles for article (PubMed ID: 23911994)
1. Structural requirements of 3-carboxyl-4(1H)-quinolones as potential antimalarials from 2D and 3D QSAR analysis.
Li J; Li S; Bai C; Liu H; Gramatica P
J Mol Graph Model; 2013 Jul; 44():266-77. PubMed ID: 23911994
[TBL] [Abstract][Full Text] [Related]
2. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
[TBL] [Abstract][Full Text] [Related]
3. 2D, 3D-QSAR and molecular docking of 4(1H)-quinolones analogues with antimalarial activities.
Jiménez Villalobos TP; Gaitán Ibarra R; Montalvo Acosta JJ
J Mol Graph Model; 2013 Nov; 46():105-24. PubMed ID: 24185373
[TBL] [Abstract][Full Text] [Related]
4. Drug discovery studies on quinoline-based derivatives as potential antimalarial agents.
Sharma R; Patil S; Maurya P
SAR QSAR Environ Res; 2014; 25(3):189-203. PubMed ID: 24601770
[TBL] [Abstract][Full Text] [Related]
5. CoMFA and CoMSIA analysis of tetrahydroquinolines as potential antimalarial agents.
Deshpande S; Jaiswal S; Katti SB; Prabhakar YS
SAR QSAR Environ Res; 2011; 22(5-6):473-88. PubMed ID: 21598193
[TBL] [Abstract][Full Text] [Related]
6. QSAR analysis of thiolactone derivatives using HQSAR, CoMFA and CoMSIA.
Sainy J; Sharma R
SAR QSAR Environ Res; 2015; 26(10):873-92. PubMed ID: 26524489
[TBL] [Abstract][Full Text] [Related]
7. Optimization of antimalarial activity of synthetic prodiginines: QSAR, GUSAR, and CoMFA analyses.
Masand VH; Mahajan DT; Patil KN; Hadda TB; Youssoufi MH; Jawarkar RD; Shibi IG
Chem Biol Drug Des; 2013 Apr; 81(4):527-36. PubMed ID: 23279875
[TBL] [Abstract][Full Text] [Related]
8. 3D QSAR studies on antimalarial alkoxylated and hydroxylated chalcones by CoMFA and CoMSIA.
Xue CX; Cui SY; Liu MC; Hu ZD; Fan BT
Eur J Med Chem; 2004 Sep; 39(9):745-53. PubMed ID: 15337287
[TBL] [Abstract][Full Text] [Related]
9. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
Bhongade BA; Gadad AK
J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035
[TBL] [Abstract][Full Text] [Related]
10. First report on exploring structural requirements of 1,2,3,4- tetrahydroacridin-9(10H)-one analogs as antimalarials using multiple QSAR approaches: descriptor-based QSAR, CoMFA-CoMSIA 3DQSAR, HQSAR and G-QSAR approaches.
Ojha PK; Roy K
Comb Chem High Throughput Screen; 2013 Jan; 16(1):7-21. PubMed ID: 23127758
[TBL] [Abstract][Full Text] [Related]
11. 3D-QSAR analysis of cycloguanil derivatives as inhibitors of A16V + S108T mutant Plasmodium falciparum dihydrofolate reductase enzyme.
Adane L; Bharatam PV
J Mol Graph Model; 2009 Nov; 28(4):357-67. PubMed ID: 19796975
[TBL] [Abstract][Full Text] [Related]
12. Exploration of important sites of antimalarial Endochins for optimum structural modification using group-based QSAR (G-QSAR) modeling.
Ojha PK; Roy K
Curr Comput Aided Drug Des; 2013 Sep; 9(3):336-49. PubMed ID: 24010932
[TBL] [Abstract][Full Text] [Related]
13. CoMFA and CoMSIA 3D-QSAR studies on quionolone caroxylic acid derivatives inhibitors of HIV-1 integrase.
Lu P; Wei X; Zhang R
Eur J Med Chem; 2010 Aug; 45(8):3413-9. PubMed ID: 20488589
[TBL] [Abstract][Full Text] [Related]
14. 3D-QSAR studies on triclosan derivatives as Plasmodium falciparum enoyl acyl carrier reductase inhibitors.
Shah P; Siddiqi MI
SAR QSAR Environ Res; 2010 Jul; 21(5-6):527-45. PubMed ID: 20818586
[TBL] [Abstract][Full Text] [Related]
15. A Combined Quantitative Structure-Activity Relationship Research of Quinolinone Derivatives as Androgen Receptor Antagonists.
Wang Y; Bai F; Cao H; Li J; Liu H; Gramatica P
Comb Chem High Throughput Screen; 2015; 18(9):834-45. PubMed ID: 26320943
[TBL] [Abstract][Full Text] [Related]
16. Structural requirements of pyrido[2,3-d]pyrimidin-7-one as CDK4/D inhibitors: 2D autocorrelation, CoMFA and CoMSIA analyses.
Caballero J; Fernández M; González-Nilo FD
Bioorg Med Chem; 2008 Jun; 16(11):6103-15. PubMed ID: 18468903
[TBL] [Abstract][Full Text] [Related]
17. New Research for Quinazoline-2,4-diones as HPPD Inhibitors Based on 2D-MLR and 3D-QSAR Models.
Fu Y; Sun YN; Cao HF; Yi KH; Zhao LX; Li JZ; Ye F
Comb Chem High Throughput Screen; 2017; 20(9):748-759. PubMed ID: 28637410
[TBL] [Abstract][Full Text] [Related]
18. Classification SAR modeling of diverse quinolone compounds for antimalarial potency against Plasmodium falciparum.
Aher RB; Roy K
Comb Chem High Throughput Screen; 2014; 17(5):396-406. PubMed ID: 24372050
[TBL] [Abstract][Full Text] [Related]
19. Discovery of new potential hits of Plasmodium falciparum enoyl-ACP reductase through ligand- and structure-based drug design approaches.
Neves BJ; Bueno RV; Braga RC; Andrade CH
Bioorg Med Chem Lett; 2013 Apr; 23(8):2436-41. PubMed ID: 23499236
[TBL] [Abstract][Full Text] [Related]
20. Computer-aided molecular design of highly potent HIV-1 RT inhibitors: 3D QSAR and molecular docking studies of efavirenz derivatives.
Pungpo P; Saparpakorn P; Wolschann P; Hannongbua S
SAR QSAR Environ Res; 2006 Aug; 17(4):353-70. PubMed ID: 16920659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
